Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
PHASE1
INTERVENTIONAL
2011-05-31
2013-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
E-health Intervention for Cancer Survivors
NCT01114802
Developing and Pre-Testing an eHealth Group Intervention for Young Adult Cancer Survivors
NCT05054569
Web-based Collaborative Care Intervention Study
NCT02939755
A Web-Based Tool to Improve Breast Cancer Survivorship
NCT03849573
Online and Narrative Interventions for Advanced Cancer Patients
NCT00948207
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The internet promises to provide inexpensive access to treatment at any time of the day or night. Unfortunately, the potential for internet delivered services has not been realized. Studies examining treatments that simply provide access to an internet site commonly result in very high dropout after the first site visit, and typically little or no improvement target symptoms. A variety of methods to improve responses to internet interventions have been examined. In general, e-mail support improves adherence and telephone support can improve adherence even more. Another type of support that has only begun to be investigated is the use of social networks to help maintain adherence.
This intervention will use an online social network, to increase adherence and promote the use of the website and the skills it teaches.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Project Onward website + 16 person social network
Project Onward website + 16 person social network
The website will include 8 weeks of Internet-based cognitive behavioral therapy combined with discussion and support from a group of up to 16 other cancer survivors.
Project Onward website + 8 person social network
Project Onward website + 8 person social network
The website will include 8 weeks of Internet-based cognitive behavioral therapy combined with discussion and support from a group of up to 8 other cancer survivors.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Project Onward website + 16 person social network
The website will include 8 weeks of Internet-based cognitive behavioral therapy combined with discussion and support from a group of up to 16 other cancer survivors.
Project Onward website + 8 person social network
The website will include 8 weeks of Internet-based cognitive behavioral therapy combined with discussion and support from a group of up to 8 other cancer survivors.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Has completed treatment for cancer and is currently in full remission.
* ECOG performance Status of \< 3.
* Has a telephone, e-mail account, computer, and broadband access to the Internet.
* Has familiarity with using the Internet that allows for adequate navigation of website.
* Is able to speak and read English.
* Is at least 19 years of age.
* Is able to give informed consent.
Exclusion Criteria
* Diagnosis of basal or squamous cell skin cancers.
19 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Northwestern University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
David Mohr
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David C. Mohr, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Northwestern University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Northwestern University
Chicago, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NU Lurie 10CC01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.